NO: The primary EDRF

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 1, 1999, Pages 5-14

  Fleming, I ^a   Busse, R ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Fluid shear stress; Gene regulation; Nitric oxide

Indexed keywords

ARGININE; AUTACOID; ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN H; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

BLOOD VESSEL TONE; CONFERENCE PAPER; HOMEOSTASIS; HUMAN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0033062909     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0839     Document Type: Conference Paper

References (84)

1. ALONSO-GALICIA M, DRUMMOND HA, REDDY KK, FALCK JR, ROMAN RJ, 1997. Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. Hypertension 29: 320-325.
2. ANDRIES LJ, BRUTSAERT DL, SYS SU, 1998. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82: 195-203.
3. ARCHER SL, HUANG JMC, HAMPL V, NELSON DP, SHULTZ PJ, WEIR EK, 1994. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 91: 7583-7587.
4. AYAJIKI K, KINDERMANN M, HECKER M, FLEMING I, BUSSE R, 1996. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res 78: 750-758.
5. BAUERSACHS J, HECKER M, BUSSE R, 1994. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 113: 1548-1553.
6. BAUERSACHS J, POPP R, HECKER M, SAUER E, FLEMING I, BUSSE R, 1996. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94: 3341-3347.
7. BAUERSACHS J, BOULOUMIE A, MÜLSCH A, WIEMER G, FLEMING I, BUSSE R, 1998. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl expression and in superoxide anion production. Cardiovasc Res 37: 772-779.
8. BENZING T, FLEMING I, BOULOUMIE A, MÜLSCH A, BUSSE R, 1998. Insulin enhances the expression of the constitutive nitric oxide synthase in native porcine aortic endothelial cells via activation or Erk1/2 and AP-1. Pflugers Arch-Eur J Physiol 435: R83 (Abstract).
9. BEVAN JA, KALEY G, RUBANYI GM, 1995. Flow-dependent Regulation of Vascular Function. New York: Oxford University Press.
10. BOLOTINA VM, NAJIBI S, PALACINO JJ, PAGANO PJ, COHEN RA, 1994. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853.
11. BOULANGER CM, GESKE RS, LÉVY BI, 1995. Angiotensin II stimulates a neuronal like NO synthase in hypertensive vascular smooth muscle. Circulation 92:I-6 (Abstract).
12. BOULOUMIE A, BAUERSACHS J, LINZ W, SCHÖLKENS BA, WIEMER G, FLEMING I, BUSSE R, 1997. Endothelial dysfunction coincides with an enhanced NO synthase expression and superoxide anion production. Hypertension 30: 934-941.
13. BOULOUMIE A, SCHINI-KERTH V, BUSSE R, 1998. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in cultured and native endothelial cells. Cardiovasc Res (in press).
14. BREDT DS, HUANG PM, GLATT CE, LOWENSTEIN C, REED RR, SNYDER SH, 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351: 714-718.
15. BROWN GC, 1995. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369: 136-139.
16. BUSSE R, MÜLSCH A, 1990. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 265: 133-136.
17. CARROLL MA, BALAZY M, MARGIOTTA P, HUANG DD, FALCK JR, MCGIFF JC, 1996. Cytochrome P-450-dependent HETEs: Profile of biological activity and stimulation by vasoactive peptides. Am J Physiol 271: R863-R869.
18. CORSON MA, JAMES NL, LATTA SE, NEREM RM, BERK BC, HARRISON DG, 1996. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 79: 984-991.
19. DAVIDGE ST, BAKER PN, MCLAUGHLIN MK, ROBERTS JM, 1995. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77: 274-283.
20. DE CATERINA R, LIBBY P, PENG H-B, THANNICKAL VJ, RAJAVASHISTH TB, GIMBRONE MA JR, SHIN WS, LIAO JK, 1995. Nitric oxide decreases cytokine-induced endothelial activation. J Clin Invest 96: 60-68.
21. DE WIT C, JAHRBECK B, SCHÄFER C, BOLZ SS, POHL U, 1998. Nitric oxide opposes myogenic pressure responses predominantly in large arterioles in vivo. Hypertension 31: 787-794.
22. EGASHIRA K, INOU T, HIROOKA Y, YAMADA A, MARUOKA Y, KAI H, SUGIMACHI M, SUZUKI S, TAKESHITA A, 1993a. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 91: 29-37.
23. EGASHIRA K, INOU T, HIROOKA Y, YAMADA A, URABE Y, TAKESHITA A, 1993b. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal angiograms. N Engl J Med 328: 1659-1664.
24. FERON O, BELHASSEN L, KOBZIK L, SMITH TW, KELLY RA, MICHEL T, 1996. Endothelial nitric oxide synthase targeting to caveolae-Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271: 22810-22814.
25. FLEMING I, BAUERSACHS J, BUSSE R, 1997. Calcium-dependent and - independent activation of the endothelial NO synthase. J Vasc Res 34: 165-174.
26. FLEMING I, BAUERSACHS J, FISSLTHALER B, BUSSE R, 1998a. Calcium-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 81: 686-695.
27. FLEMING I, BUSSE R, 1997. Vascular effects of NO. In: Goligorsky M and Gross SS (eds), Nitric Oxide and the Kidney: Physiology and Pathophysiology. New York: Chapman & Hall, 161-175.
28. FLEMING I, FISSLTHALER B, BUSSE R, 1998b. Shear stress-induced phosphorylation of the endothelial NO synthase. Nitric Oxide 2: 76 (Abstract).
29. FLEMING I, HECKER M, BUSSE R, 1994. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res 74: 1220-1226.
30. FÖRSTERMANN U, BOISSEL J-P, KLEINERT H, 1998. Expressional control of the "constitutive" isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12: 790.
31. + channels in the vasodilator response to bradykinin in the rat heart. Br J Pharmacol 113: 954-958.
32. FURCHGOTT RF, 1988. Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activable inhibitory factor from bovine retractor penis is organic nitrite and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte PM (Ed.), Mechanisms of Vasodilation. New York: Raven Press, 401-418.
33. FURCHGOTT RF, ZAWADZKI JV, 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
34. GARCÍA-CARDENA G, FAN G, STERN DF, LIU J, SESSA WC, 1996a. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 271: 27237-27240.
35. GARCÍA-CARDENA G, OH P, LIU J, SCHNITZER JE, SESSA WC, 1996b. Targeting of nitric oxide synthase to endothelial caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453.
36. GARCÍA-CARDENA G, MARTASEK P, MASTERS BS, SKIDD PM, COUET J, LI SW, LISANTI MP, SESSA WC, 1997. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin-Functional significance of the NOS caveolin binding domain in vivo. J Biol Chem 272: 25437-25440.
37. GARCÍA-CARDENA G, FAN R, SHAH V, SORRENTINO R, CIRINO G, PAPAPETROPOULOS A, SESSA WC, 1998. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 292: 821-824.
38. HARDER DR, LANGE AR, GEBREMEDHIN D, BIRKS EK, ROMAN RJ, 1997. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 34: 237-243.
39. HECKER M, BARA AT, BAUERSACHS J, BUSSE R, 1994. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Lond) 481: 407-414.
40. HIRATA K, KURODA R, SAKODA T, KATAYAMA M, INOUE N, SUEMATSU M, KAWASHIMA S, YOKOYAMA M, 1995. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25: 180-185.
41. HOOD JD, MEININGER CJ, ZICHE M, GRANGER HJ, 1998. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol Heart Circ Phy 43: H1054-H1058.
42. HUANG PL, HUANG Z, MASHIMO H, BLOCH KD, MOSKOWITZ MA, BEVAN JA, FISHMAN MC, 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242.
43. IGNARRO LJ, BYRNS R, BUGA GM, WOOD RS, CHAUDHURI G, 1987. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study the endothelium-dependent and nitric oxide elicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 244:181-189.
44. IMIG JD, Zou AP, STEC DE, HARDER DR, FALCK JR, ROMAN RJ, 1996. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 270: R217-R227.
45. JIA L, BONAVENTURA C, BONAVENTURA J, STAMLER JS, 1996. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226.
46. KOMORI K, VANHOUTTE PM, 1990. Endothelium-derived hyperpolarizing factor. Blood Vessels 27: 238-245.
47. KUCHAN MJ, FRANCOS JA, 1994. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 266: C628-C636.
48. LAMONTAGNE D, POHL U, BUSSE R, 1992. Mechanical deformation of the vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70: 123-130.
49. Liu J, GARCÍA-CARDENA G, SESSA WC, 1995. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/ or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry 34: 12333-12340.
50. Liu J, HUGHES TE, SESSA WC, 1997. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol 137: 1525-1535.
51. MA Y-H, GEBREMEDHIN D, SCHWARTZMAN M, FALCK JR, MASTERS BS, HARDER DR, ROMAN RJ, 1997. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72: 136.
52. MASTICK CC, BRADY MJ, SALTIEL AR, 1995. Insulin stimulates the tyrosine phosphorylation of caveolin. J Cell Biol 129: 1523-1531.
53. MCCULLOCH AI, BOTTRILL FE, RANDALL MD, HILEY CR, 1997. Characterization and modulation of EDHF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br J Pharmacol 120: 1431-1438.
54. MICHEL T, FERON O, 1997. Nitric oxide synthases: which, where, how and why? J Clin Invest 100: 2146-2152.
55. MICHEL T, LI GK, BUSCONI L, 1993. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 90: 6252-6256.
56. Ca) in smooth muscle cells isolated from the rat mesenteric artery. Br J Pharmacol 124: 1131-1140.
57. MIYAMOTO Y, SAITO Y, KAJIYAMA N, YOSHIMURA M, SHIMASAKI Y, NAKAYAMA M, KAMITANI S, HARADA M, ISHIKAWA M, KUWAHARA K, OGAWA E, HAMANAKA I, TAKAHASHI N, KANESHIGE T, TERAOKA H, AKAMIZU T, AZUMA N, YOSHIMASA Y, YOSHIMASA T, ITHO H, MASUDA I, YASUE H, NAKAO K, 1998. Endothelial nitric oxide synthase gene expression is positively associated with essential hypertension. Hypertension 32: 3-8.
58. MOOLENAAR WH, 1994. LPA: a novel lipid mediator with diverse biological actions. Trends Cell Biol 4: 213-218.
59. MÜGGE A, ELWELL JH, PETERSON TE, HOFMEYER TG, HEISTAD DD, HARRISON DG, 1991. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res 69: 1293-1300.
60. NISHIDA K, HARRISON DG, NAVAS JP, FISHER AA, DOCKERY SP, UEMATSU M, NEREM RM, ALEXANDER RW, MURPHY TJ, 1992. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90: 2092-2096.
61. OKAMOTO T, SCHLEGEL A, SCHERER PE, LISANTI MP, 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422.
62. OLMOS L, MOMBOULI J-V, ILLIANO S, VANHOUTTE PM, 1995. cGMP mediates desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol 268: H865-H870.
63. PALMER RMJ, FERRIDGE AG, MONCADA S, 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526.
64. PAPAPETROPOULOS A, ABOU-MOHAMED G, MARCZIN N, MURAD F, CALERA MR, CATRAVAS JD, 1996a. Down-regulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or inter-leukin-1β. Br J Pharmacol 118: 1359-1366.
65. PAPAPETROPOULOS A, Go C, MURAD F, CATRAVAS JD, 1996b. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br J Pharmacol 117: 147-155.
66. PAPAPETROPOULOS A, GARCIACARDENA G, MADRI JA, SESSA WC, 1997. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139.
67. PRATT WB, 1997. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptor signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37: 297-326.
68. RAJOTTE D, ARAP W, HAGEDORN M, KOLVUNEN E, PASQUALINI R, RUOSLAHTI E, 1998. Molecular heterogeneity of the vascular endothelium revealed by in vitro phage display. J Clin Invest 102: 430-437.
69. REDDY KG, NAIR RN, SHEEHAN HM, HODGSON JM, 1994. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 23: 833-843.
70. ROBINSON LJ, BUSCONI L, MICHEL T, 1995. Agonist-modulated palmitoylation of endothelial nitric oxide synthase. J Biol Chem 270: 995-998.
71. ROSENKRANZ-WEISS P, SESSA WC, MILSTIEN S, KAUFMAN S, WATSON CA, POBER JS, 1994. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. J Clin Invest 93: 2236-2243.
72. RUBANYI GM, VANHOUTTE PM, 1987. Nature of endothelium-derived relaxing factor: are there two relaxing mediators? Circ Res 61 (Suppl. II): II-61-II-67.
73. SALVEMINI D, MISKO TP, MASFERRER JL, SIEBERT K, CURRIE MG, NEEDLEMAN P, 1993. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244.
74. SALVEMINI D, SEIBERT K, MASFERRER JL, MISKO TP, CURRIE MG, NEEDLEMAN P, 1994. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 93: 1940-1947.
75. SAUTEBIN L, IALENTI A, IANARO A, Di ROSA M, 1995. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br J Pharmacol 114: 323-328.
76. 2+ currents in aveolar epithelial cells. Am J Physiol 272: L1092-L1097.
77. TAKEUCHI T, KISHI M, ISHII T, NISHIO H, HATA F, 1996. Nitric oxide-mediated relaxation without concomitant changes in cyclic GMP content of rat proximal colon. Br J Pharmacol 117: 1204-1208.
78. VENEMA RC, SAYEGH HS, ARNAL J-F, HARRISON DG, 1995. Role of enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J Biol Chem 270: 14705-14711.
79. VENEMA VJ, MARRERO MB, VENEMA RC, 1996. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 226: 703-710.
80. YOSHIZUMI M, PERRELLA MA, BURNETT JC JR, LEE M-E, 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73: 205-209.
81. ZEIHER AM, DREXLER H, WOLLSCHLÄGER H, JUST H, 1991a. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391-401.
82. ZEIHER AM, DREXLER H, WOLLSCHLÄGER H, JUST H, 1991b. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 84: 1984-1992.
83. ZEIHER AM, FISSLTHALER B, SCHRAY-UTZ B, BUSSE R, 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76: 980-986.
84. + channel in renal arterioles. Am J Physiol 270: R228-R237.